SILENT INFLAMMATION IS LINKED TO ENDOTHELIAL DYSFUNCTION IN CHILDHOOD NEPHROTIC SYNDROME

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
SILENT INFLAMMATION IS LINKED TO ENDOTHELIAL DYSFUNCTION IN CHILDHOOD NEPHROTIC SYNDROME

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Melonie
Phillips
Md Imtiaz Islam MdImtiazul.Islam@nationwidechildrens.org Nationwide Children's Hospital Nephrology Columbus United States -
Melonie Phillips Melonie.Phillips@nationwidechildrens.org Nationwide Children's Hospital Nephrology Columbus United States *
Audrey Fetsko Audrey.Fetsko@nationwidechildrens.org Nationwide Children's Hospital Nephrology Columbus United States -
Lorenzo Annesi Lorenzo.Annesi@nationwidechildrens.org Nationwide Children's Hospital Nephrology Columbus United States -
Xin Wang Xin.Wang@nationwidechildrens.org Nationwide Children's Hospital Nephrology Columbus United States -
Nelofar Nargis Nelofar.Nargis@nationwidechildrens.org Nationwide Children's Hospital Nephrology Columbus United States -
Carmen de Lucas-Collantes mcdelucas@yahoo.es Hospital Niño Jesus Nephrology Madrid Spain -
Flor Angel Ordόñez-Álvarez faordonez1968@gmail.com Hospital Universitario Central de Asturias Pediatric Nephrology Oviedo Spain -
Antonia Bouts a.h.bouts@amsterdamumc.nl AMC Amsterdam Pediatric Nephrology Amsterdam Netherlands -
Shoji Tsuji tsuji.sho@kmu.ac.jp Kansai Medical School Kansai Medical School Osaka Japan -
Kazunari Kaneko kaneko.kaz@kmu.ac.jp Kansai Medical School Kansai Medical School Osaka Japan -
Gabriel Cara Fuentes gabriel.carafuentes@nationwidechildrens.org Nationwide Children's Hospital Pediatric Nephrology Columbus United States -
-
-
-

Endothelial dysfunction is increasingly recognized in childhood idiopathic nephrotic syndrome (INS), but this remains an understudied field. We tested the hypothesis that silent inflammation is linked to endothelial dysfunction.

The study includes 128 children with INS and 34 healthy participants (n=22 adults, n=12 children). In serum, we measured levels of TNFR1 and TNFR2 (inflammation) and angiopoietin-2 (Ang-2) (endothelial activation) using an automated immunoassay system. In kidney tissue, we analyzed expression of the same targets using available RNAseq datasets. We performed in vitro studies to test the effect of INS sera on human glomerular endothelial cells (GEnC).

Serum TNFR1, TNFR2 and Ang-2 levels were higher in INS patients with new onset INS or in relapse compared to controls; and levels were above normal range in ~30% of patients in remission. There was a strong correlation between serum TNFR1 and TNFR2, and between these markers and Ang-2. Higher serum TNFR1 and TNFR2 levels, but not Ang-2, associated with higher proteinuria and hypoalbuminemia. TNFR1 and TNFR2 mRNA expression was increased in several kidney cells, including endothelium, in patients with INS. TNFR1 and TNFR2 mRNA expression in kidney endothelial cells positively correlated with Ang-2 mRNA levels. Serum from INS patients activated GEnC as noted by the increase in Ang-2 mRNA expression, release of Ang-2 from GEnC lysates, and  increased glucocorticoid receptor expression. Dexamethasone prevented GEnC activation by INS sera.  

Silent inflammation is linked to endothelial dysfunction in INS; and steroids directly mitigate GEnC activation in these patients.  

Kewords